p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme

被引：0
|
作者：
Jiao Meng
Wei Qian
Zhenkun Yang
Lingli Gong
Daxing Xu
Hongbo Huang
Xinyi Jiang
Zhening Pu
Ying Yin
Jian Zou
机构：
[1] The Affiliated Wuxi People’s Hospital of Nanjing Medical University,Department of Laboratory Medicine, Wuxi People’s Hospital, Wuxi Medical Center
[2] Nanjing Medical University,Center of Clinical Research, Wuxi People’s Hospital, Wuxi Medical Center
[3] The Affiliated Wuxi People’s Hospital of Nanjing Medical University,NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine
[4] Nanjing Medical University, Department of Clinical Laborator
[5] Jiangsu Institute of Nuclear Medicine,undefined
[6] Kunshan Hospital of Traditional Chinese Medicine,undefined
[7] Kunshan,undefined
来源：
BMC Cancer | / 24卷
关键词：
E2F7; p53; Chemoresistance; Temozolomide; Glioblastoma multiforme;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] DETECTION OF P53 MUTATIONS IN PROLIFERATING VASCULAR CELLS IN GLIOBLASTOMA MULTIFORME
    Takeshima, H.
    NEURO-ONCOLOGY, 2016, 18 : 55 - 55
  • [22] Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme
    Kawasoe, Takuma
    Takeshima, Hideo
    Yamashita, Shinji
    Mizuguchi, Sohei
    Fukushima, Tsuyoshi
    Yokogami, Kiyotaka
    Yamasaki, Kouji
    JOURNAL OF NEUROSURGERY, 2015, 122 (02) : 317 - 323
  • [23] Targeting the HuR/E2F7 axis synergizes with bortezomib against multiple myeloma
    Jia, Ming-yuan
    Wu, Chao
    Fu, Ze
    Xu, Wen-bin
    Liu, Jia
    Wu, Cheng-yu
    Zeng, Xin-yi
    Wu, Ying-li
    Yan, Hua
    ACTA PHARMACOLOGICA SINICA, 2025,
  • [24] p53/E2F1/miR-25 axis regulates apoptosis induction in glioblastoma cells: a qualitative model
    Silveira, Daner A.
    Gupta, Shantanu
    Mombach, Jose Carlos M.
    JOURNAL OF PHYSICS-COMPLEXITY, 2020, 1 (03):
  • [25] SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7
    Zi-Mu Zhang
    Hai-Bo Cao
    Zhi-Heng Li
    Ran Zhuo
    Yan-Fang Tao
    Xiao-Lu Li
    Gen Li
    Xin-Mei Liao
    Fang Fang
    Yi Xie
    Di Wu
    Hai-Rong Wang
    Jian-Wei Wang
    Yan-Ling Chen
    Juan-Juan Yu
    Si-Qi Jia
    Ran-Dong Yang
    Xin-Yi Guo
    Yang Yang
    Chen-Xi Feng
    Yun-Yun Xu
    Guang-Hui Qian
    Jian Pan
    Cell Death & Disease, 13
  • [26] Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis
    Lu, Tianyu
    Wang, Rui
    Cai, Hongfei
    Cui, Youbin
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 123
  • [27] Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F
    T Hershko
    M Chaussepied
    M Oren
    D Ginsberg
    Cell Death & Differentiation, 2005, 12 : 377 - 383
  • [28] The non-genotoxic activator of the p53 pathway Nutlin-3 shifts the balance between E2F7 and E2F1 transcription factors in leukemic cells
    di Iasio, Maria Grazia
    Zauli, Giorgio
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (02) : 458 - 460
  • [29] Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F
    Hershko, T
    Chaussepied, M
    Oren, M
    Ginsberg, D
    CELL DEATH AND DIFFERENTIATION, 2005, 12 (04): : 377 - 383
  • [30] SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7
    Zhang, Zi-Mu
    Cao, Hai-Bo
    Li, Zhi-Heng
    Zhuo, Ran
    Tao, Yan-Fang
    Li, Xiao-Lu
    Li, Gen
    Liao, Xin-Mei
    Fang, Fang
    Xie, Yi
    Wu, Di
    Wang, Hai-Rong
    Wang, Jian-Wei
    Chen, Yan-Ling
    Yu, Juan-Juan
    Jia, Si-Qi
    Yang, Ran-Dong
    Guo, Xin-Yi
    Yang, Yang
    Feng, Chen-Xi
    Xu, Yun-Yun
    Qian, Guang-Hui
    Pan, Jian
    CELL DEATH & DISEASE, 2022, 13 (02)
12345